NASDAQ:UPI - Uroplasty Stock Price, Price Target & More

$1.22 0.00 (0.00 %)

(As of 04/20/2018 10:51 AM ET)

Previous Close$1.22

Today's RangeN/A

52-Week Range$1.05 - $4.05

VolumeN/A

Average Volume124,964 shs

Market Capitalization$27.68 million

P/E RatioN/A

Dividend YieldN/A

Beta-1.26

About Uroplasty (NASDAQ:UPI)

Cogentix Medical, Inc. (Cogentix Medical) is a medical device company. The Company is engaged in the design, development, manufacturing and marketing of products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, known as EndoSheath technology, providing users with endoscope turnover. The Company's products include Urgent PC Neuromodulation System, Macroplastique Bulking Agent, Endoscopy Systems and EndoSheath Technology. The Company is also engaged in the commercialization of the Urgent PC Neuromodulation System, a device which delivers percutaneous tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder (OAB). Its Macroplastique is an injectable soft-tissue bulking agent used to treat stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD). The Company offers 5000 and 7000 series of endoscopes, which are video endoscopy systems.

Receive UPI News and Ratings via Email

Sign-up to receive the latest news and ratings for UPI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A

Sub-IndustryN/A

SectorN/A

SymbolNASDAQ:UPI

CUSIPN/A

Webwww.uroplasty.com

Phone+1-952-4266140

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / CashN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net Margins-31.58%

Return on Equity-87.33%

Return on Assets-60.82%

Miscellaneous

EmployeesN/A

Outstanding Shares22,150,000

How to Become a New Pot Stock Millionaire

Uroplasty (NASDAQ:UPI) Frequently Asked Questions

What is Uroplasty's stock symbol?

Uroplasty trades on the NASDAQ under the ticker symbol "UPI."

How were Uroplasty's earnings last quarter?

Uroplasty, Inc. (NASDAQ:UPI) announced its quarterly earnings data on Thursday, January, 22nd. The medical device company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.02. The medical device company had revenue of $6.67 million for the quarter, compared to analyst estimates of $6.89 million. Uroplasty had a negative net margin of 31.58% and a negative return on equity of 87.33%. View Uroplasty's Earnings History.

Who are some of Uroplasty's key competitors?

Some companies that are related to Uroplasty include Mid-Con Energy (MCEP), Evine (EVLV), Identiv (INVE), Famous Dave's (DAVE), Turtle Beach (HEAR), Senomyx (SNMX), Pain Therapeutics (PTIE), Catabasis Pharmaceuticals (CATB), Zosano Pharma (ZSAN), NetSol Technologies (NTWK), Opiant Pharmaceuticals (OPNT), Support.com (SPRT), Neovasc (NVCN), Tintri (TNTR), Westell Technologies (WSTL), Perma-Fix Environmental Services (PESI), Verenium (VRNM) and TRACON Pharmaceuticals (TCON).

Has Uroplasty been receiving favorable news coverage?

Press coverage about UPI stock has been trending somewhat positive recently, according to Accern. Accern identifies negative and positive news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Uroplasty earned a media sentiment score of 0.04 on Accern's scale. They also assigned news headlines about the medical device company an impact score of 45.65 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Uroplasty?

Shares of UPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Uroplasty's stock price today?

One share of UPI stock can currently be purchased for approximately $1.22.

How big of a company is Uroplasty?

Uroplasty has a market capitalization of $27.68 million.

How can I contact Uroplasty?

Uroplasty's mailing address is 5420 Feltl Road, MINNETONKA, MN 55343, United States. The medical device company can be reached via phone at +1-952-4266140.

MarketBeat Community Rating for Uroplasty (UPI)

Community Ranking:		2.7 out of 5 ( )
Outperform Votes:		79 (Vote Outperform)
Underperform Votes:		67 (Vote Underperform)
Total Votes:		146

MarketBeat's community ratings are surveys of what our community members think about Uroplasty and other stocks. Vote "Outperform" if you believe UPI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe UPI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Uroplasty (NASDAQ:UPI) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details

(Data available from 4/20/2016 forward)

Uroplasty (NASDAQ:UPI) Earnings History and Estimates Chart

Earnings by Quarter for Uroplasty (NASDAQ:UPI)

Uroplasty (NASDAQ UPI) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
1/22/2015	Q3	($0.04)	($0.06)	$6.89 million	$6.67 million	View	Listen
10/23/2014	Q2	($0.07)	($0.05)	$6.49 million	$6.46 million	View	Listen
7/24/2014	Q1	($0.05)	($0.10)	$6.35 million	$6.39 million	View	Listen
5/15/2014	Q4 13	($0.04)	($0.05)	$6.40 million	$6.36 million	View	N/A
1/23/2014	Q314	($0.04)	($0.03)	$6.13 million	$6.40 million	View	Listen
10/24/2013	Q214	($0.05)	($0.04)	$6.09 million	$6.00 million	View	Listen
8/1/2013	Q1 2014	($0.05)	($0.08)	$5.60 million	$5.84 million	View	N/A
5/30/2013	Q4 2013	($0.04)	($0.05)	$5.59 million	$5.54 million	View	Listen
1/24/2013	Q3 2013	($0.04)	($0.02)			View	N/A
10/25/2012	Q2 2013	($0.05)	($0.03)			View	N/A
7/26/2012	Q1 2013	($0.04)	($0.05)			View	N/A
5/24/2012	Q4 2012	($0.07)	($0.03)			View	N/A
1/26/2012	Q3 2012	($0.08)	($0.05)			View	N/A
10/27/2011	Q2 2012	($0.08)	($0.06)			View	N/A
7/28/2011	Q1 2012	($0.07)	($0.06)			View	N/A
5/25/2011	Q4 2011	($0.07)	($0.06)			View	N/A
1/27/2011	Q3 2011	($0.07)	($0.07)			View	N/A
10/27/2010	Q2 2011	($0.07)	($0.05)			View	N/A
8/10/2010	Q1 2011		($0.06)			View	N/A
5/27/2010	Q4 2010		($0.04)			View	N/A
2/1/2010	Q3 2010		($0.03)			View	N/A
11/2/2009	Q2 2010		($0.06)			View	N/A
8/3/2009	Q1 2010		($0.09)			View	N/A
6/4/2009	Q4 2009		($0.11)			View	N/A
2/3/2009	Q3 2009		($0.06)			View	N/A
10/29/2008	Q2 2009		($0.04)			View	N/A
7/31/2008	Q1 2009		($0.03)			View	N/A
6/3/2008	Q4 2008		($0.05)			View	N/A
2/11/2008	Q3 2008		($0.05)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Uroplasty (NASDAQ:UPI) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Uroplasty (NASDAQ UPI) Insider Trading and Institutional Ownership History

Insider Trading History for Uroplasty (NASDAQ:UPI)

Uroplasty (NASDAQ UPI) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/30/2015	Brett Reynolds	CFO	Buy	5,000	$1.32	$6,600.00
1/29/2015	Kevin H Roche	Director	Buy	50,000	$1.23	$61,500.00
1/29/2015	Robert Kill	CEO	Buy	25,000	$1.26	$31,500.00
7/30/2014	Kevin H Roche	Director	Buy	10,000	$2.45	$24,500.00
7/29/2014	Kevin H Roche	Director	Buy	9,000	$2.44	$21,960.00
6/3/2014	Kevin H Roche	Director	Buy	10,000	$2.97	$29,700.00
6/2/2014	Robert Kill	CEO	Buy	13,950	$2.95	$41,152.50
3/6/2014	Susan Hartjes Holman	VP	Sell	38,000	$3.98	$151,240.00	274,680
1/29/2014	Susan Hartjes Holman	SVP	Sell	52,500	$4.59	$240,975.00	312,680
12/11/2013	Robert Patrick Maxwell	Director	Sell	3,819	$2.70	$10,311.30	136,584
8/23/2013	Brett Reynolds	CFO	Buy	8,000	$2.99	$23,920.00	58,000
8/23/2013	James Stauner	Director	Buy	8,300	$3.03	$25,149.00	35,450
8/7/2013	Robert Kill	CEO	Buy	36,050	$2.77	$99,858.50	346,050
8/6/2013	Darin Hammers	VP	Buy	6,800	$2.82	$19,176.00	6,800

(Data available from 1/1/2013 forward)

Uroplasty (NASDAQ UPI) News Headlines

Source:

Date	Headline
	Critical Analysis: Uroplasty (UPI) vs. ConforMIS (CFMS) www.americanbankingnews.com - February 25 at 5:20 AM
	Critical Survey: Uroplasty (UPI) versus Amedica (AMDA) www.americanbankingnews.com - February 24 at 3:02 PM
	RTI Surgical (RTIX) versus Uroplasty (UPI) Financial Review www.americanbankingnews.com - February 21 at 5:06 AM
	Critical Analysis: Cerus (CERS) vs. Uroplasty (UPI) www.americanbankingnews.com - February 1 at 11:43 AM
	Contrasting Obalon Therapeutics (OBLN) and Uroplasty (UPI) www.americanbankingnews.com - January 3 at 5:36 PM
	Comparing Uroplasty (UPI) and Endologix (ELGX) www.americanbankingnews.com - January 3 at 5:34 AM
	Smith & Nephew SNATS (SNN) versus Uroplasty (UPI) Financial Review www.americanbankingnews.com - December 18 at 8:18 AM
	Analyzing Smith & Nephew SNATS (SNN) & Uroplasty (UPI) www.americanbankingnews.com - December 16 at 5:10 PM
	Analyzing Second Sight Medical Products (EYES) & Uroplasty (UPI) www.americanbankingnews.com - December 13 at 9:18 PM
	Uroplasty (UPI) vs. The Competition Financial Comparison www.americanbankingnews.com - December 13 at 5:38 PM
	Head to Head Analysis: Uroplasty (UPI) vs. Glaukos (GKOS) www.americanbankingnews.com - December 13 at 3:54 PM
	Uroplasty (UPI) and The Competition Head-To-Head Survey www.americanbankingnews.com - December 13 at 1:34 PM
	Head to Head Analysis: Uroplasty (UPI) and Its Peers www.americanbankingnews.com - December 12 at 5:16 PM
	Head to Head Survey: Uroplasty (UPI) vs. Its Rivals www.americanbankingnews.com - December 11 at 9:30 PM
	Reviewing Uroplasty (UPI) and The Competition www.americanbankingnews.com - December 10 at 5:22 PM
	Head to Head Analysis: Uroplasty (UPI) & Its Competitors www.americanbankingnews.com - December 10 at 3:30 PM
	Comparing Uroplasty (UPI) & The Competition www.americanbankingnews.com - December 10 at 12:14 PM
	Contrasting Uroplasty (UPI) and The Competition www.americanbankingnews.com - December 9 at 7:18 PM
	Uroplasty (UPI) and Its Peers Head-To-Head Contrast www.americanbankingnews.com - December 9 at 5:30 AM
	Financial Review: Uroplasty (UPI) & The Competition www.americanbankingnews.com - December 9 at 5:30 AM
	Uroplasty (UPI) and The Competition Financial Review www.americanbankingnews.com - December 7 at 7:28 PM
	Uroplasty (UPI) vs. Its Peers Critical Analysis www.americanbankingnews.com - December 7 at 9:24 AM
	Head to Head Comparison: Uroplasty (UPI) & Its Rivals www.americanbankingnews.com - December 6 at 5:30 PM
	Critical Survey: Uroplasty (UPI) and The Competition www.americanbankingnews.com - December 6 at 3:12 AM
	Reviewing Uroplasty (UPI) and Its Peers www.americanbankingnews.com - December 5 at 5:26 PM
	Uroplasty (UPI) vs. The Competition Financial Review www.americanbankingnews.com - December 5 at 5:28 AM
	Uroplasty (UPI) & Its Peers Critical Contrast www.americanbankingnews.com - December 4 at 1:28 PM
	Contrasting Uroplasty (UPI) & Its Peers www.americanbankingnews.com - December 4 at 8:44 AM
	Financial Analysis: St Jude Medical (STJ) vs. Uroplasty (UPI) www.americanbankingnews.com - December 3 at 1:24 AM
	Uroplasty (UPI) versus Its Rivals Critical Review www.americanbankingnews.com - November 30 at 7:26 PM
	Uroplasty (UPI) vs. Its Peers Head to Head Contrast www.americanbankingnews.com - November 29 at 11:32 PM
	Comparing Uroplasty (UPI) and Its Peers www.americanbankingnews.com - November 28 at 3:31 AM
	Uroplasty (UPI) & Its Peers Head-To-Head Comparison www.americanbankingnews.com - November 27 at 9:36 AM
	Head-To-Head Contrast: Uroplasty (UPI) vs. Its Rivals www.americanbankingnews.com - November 25 at 11:04 PM
	Uroplasty (UPI) & Its Peers Head to Head Analysis www.americanbankingnews.com - November 25 at 5:10 AM
	Head-To-Head Analysis: Uroplasty (UPI) vs. The Competition www.americanbankingnews.com - November 24 at 11:16 PM
	Uroplasty (UPI) vs. Its Peers Head to Head Review www.americanbankingnews.com - November 23 at 9:16 PM
	Contrasting Uroplasty (UPI) & Its Rivals www.americanbankingnews.com - November 22 at 11:10 PM
	Uroplasty (UPI) & Its Rivals Head to Head Comparison www.americanbankingnews.com - November 21 at 7:43 AM
	Uroplasty (UPI) vs. The Competition Financial Analysis www.americanbankingnews.com - November 18 at 5:20 PM
	Analyzing Uroplasty (UPI) and Second Sight Medical Products (EYES) www.americanbankingnews.com - November 16 at 10:28 AM
	Uroplasty (UPI) vs. The Competition Head-To-Head Survey www.americanbankingnews.com - November 14 at 9:22 PM
	Uroplasty (UPI) versus Its Rivals Financial Analysis www.americanbankingnews.com - November 14 at 7:18 PM

Uroplasty (NASDAQ:UPI) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Uroplasty (NASDAQ:UPI) Income Statement, Balance Sheet and Cash Flow Statement

Uroplasty (NASDAQ UPI) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff